×
COMPASS Pathways Inventory 2019-2025 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
COMPASS Pathways inventory from 2019 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
View More
COMPASS Pathways Inventory 2019-2025 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
COMPASS Pathways inventory from 2019 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.4B
CVS Health (CVS)
$92.8B
Elevance Health (ELV)
$71.8B
Cencora (COR)
$56.5B
DiDi Global (DIDIY)
$27.5B
Labcorp Holdings (LH)
$23.1B
Natera (NTRA)
$23.1B
BioMerieux (BMXMF)
$16.6B
EUROFINS SCIENT (ERFSF)
$14.6B
ICON (ICLR)
$14.4B
Medpace Holdings (MEDP)
$13.4B
CochLear (CHEOY)
$12.9B
Solventum (SOLV)
$12.7B
Viatris (VTRS)
$12.3B
Caris Life Sciences,�Inc (CAI)
$10.8B
Revvity (RVTY)
$10.5B
Avantor (AVTR)
$9.2B
Charles River Laboratories (CRL)
$8B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.7B
Bausch + Lomb (BLCO)
$5.2B
Sotera Health (SHC)
$4.6B
BrightSpring Health Services (BTSG)
$4.2B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.7B
Alignment Healthcare (ALHC)
$3.2B
Concentras Parent (CON)
$3.1B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B
Premier (PINC)
$2.1B